Effects on Intraocular Pressure during Cataract Surgery with Intravenous Remifentanyl and Dexmedetomidine - A Comparative Study

Aims and objectives: To compare the effects of intravenous infusion of remifentanil and dexmedetomidine on the intraocular pressure (IOP) of patients who underwent cataract surgery. Methods: Ninety consecutive patients aged between 20 and 65 who had been scheduled for elective cataract surgery were included in the study. Patients were divided into 3 groups as control (Group C), remifentanil infusion (Group R) and dexmedetomidine infusion (Group D). Preoperative intraocular pressures and hemodynamics were evaluated. Results: According to intraocular pressure levels, although the IOP decreased at the drug loading dose, induction, it was statistically significantly higher in Group C than in Group R and Group D (p< 0.001). However, in these periods there was no statistically significant difference between Group R and Group D. In the postoperative period, the IOP measurements of Group D were significantly lower than those of Group C and Group R, 16.81±1.65 mm Hg, 18.21±1.98 mm Hg, 18.17±1.29 mm Hg, respectively (p< 0.002). Blood pressure and heart rate values decreased more in Group R and Group D compared to Group C during the operation (p < 0.001). Conclusions: Remifentanil and dexmedetomidine are agents that can be used in intravenous infusions for controlled hypo tension in eye surgeries where low IOP is desired. Intraoperative hemodynamic effects are similar. However, considering that it decreases IOP values more in the intraoperative period and lowers IOP values in the postoperative period compared to remifentanil, we believe that dexmedetomidine can be preferred primarily. J.Natl.Inst.Ophthalmol.2025;8(1): 36-41

Authors

Institutions

Publication Details

Journal
Journal of National Institute of Ophthalmology
Published
2026-10-15
DOI
https://doi.org/10.3329/jnio.v8i1.94291
Primary Topic
Anesthesia and Sedative Agents
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects on Intraocular Pressure during Cataract Surgery with Intravenous Remifentanyl and Dexmedetomidine - A Comparative Study

Chandan Kumar Banik, Prosanjit Mazumder, Gopa Kundu, Basudeb Das et al.
Journal of National Institute of Ophthalmology
Anesthesia and Sedative Agents
article

Effects on Intraocular Pressure during Cataract Surgery with Intravenous Remifentanyl and Dexmedetomidine - A Comparative Study

Chandan Kumar Banik, Prosanjit Mazumder, Gopa Kundu, Basudeb Das, Md Hassan Sazu, Khaled Jahan Fahim
article en

Abstract

Aims and objectives: To compare the effects of intravenous infusion of remifentanil and dexmedetomidine on the intraocular pressure (IOP) of patients who underwent cataract surgery. Methods: Ninety consecutive patients aged between 20 and 65 who had been scheduled for elective cataract surgery were included in the study. Patients were divided into 3 groups as control (Group C), remifentanil infusion (Group R) and dexmedetomidine infusion (Group D). Preoperative intraocular pressures and hemodynamics were evaluated. Results: According to intraocular pressure levels, although the IOP decreased at the drug loading dose, induction, it was statistically significantly higher in Group C than in Group R and Group D (p< 0.001). However, in these periods there was no statistically significant difference between Group R and Group D. In the postoperative period, the IOP measurements of Group D were significantly lower than those of Group C and Group R, 16.81±1.65 mm Hg, 18.21±1.98 mm Hg, 18.17±1.29 mm Hg, respectively (p< 0.002). Blood pressure and heart rate values decreased more in Group R and Group D compared to Group C during the operation (p < 0.001). Conclusions: Remifentanil and dexmedetomidine are agents that can be used in intravenous infusions for controlled hypo tension in eye surgeries where low IOP is desired. Intraoperative hemodynamic effects are similar. However, considering that it decreases IOP values more in the intraoperative period and lowers IOP values in the postoperative period compared to remifentanil, we believe that dexmedetomidine can be preferred primarily. J.Natl.Inst.Ophthalmol.2025;8(1): 36-41

Journal of National Institute of OphthalmologyVol. 8(1)
National Institute of Neurosciences & Hospital (BD), National Institute of Cardiovascular Diseases (BD), National Institute of Cancer Research and Hospital (BD)
Good health and well-being
Openalex Percentile: Top 9%
Anesthesia and Sedative Agents
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.